Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 2 days agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
Covid vaccines may have helped fuel rise in excess deaths
The Telegraph via Yahoo News· 4 days agoWriting in the BMJ Public Health, the authors from Vrije Universiteit, Amsterdam, said: “Although ...
Study finds no association between COVID-19 vaccines and stillbirths
Medical Xpress· 46 minutes agoIn the case-control study led by Yale School of Medicine's Dr. Anna Denoble, researchers compared...
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 5 hours agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 2 days agoThe recommendations follow a recent assessment by the World Health Organization that vaccines should...
A New COVID Booster Targeting JN.1 May Arrive This Fall
Verywell Health via Yahoo News· 48 minutes agoAn FDA panel voted to recommend an updated COVID-19 vaccine targeting the JN.1 variant. Here's what...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via Yahoo Finance· 2 hours agoThe submission is based on FDA guidance, which advised that COVID-19 vaccines should be updated to a...
FDA panel recommends new COVID-19 vaccine formula for fall
UPI· 1 day agovaccine makers to focus on the latest versions of the virus, and not the JN.1 variant. A U.S. Food...
Excess deaths remained elevated even after COVID-19 vaccines, study finds
The Center Square· 3 days agoThe study, published in BMJ Public Health, found more research is needed to determine why more...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
The Kansas City Star· 3 hours agoManufacturing is underway and doses of Moderna’s Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval